Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice

Background: The debate around the cost-effectiveness of gene therapy for hemophilia has largely centered on its price (€1-€3.5 million per individual). While previous studies have explored care organization for gene therapy delivery, none have evaluated the potential resource utilization and associa...

Повний опис

Бібліографічні деталі

Автори:	Diaz M. Prameyllawati, Caroline M.A. Mussert, Martijn A.H. Oude Voshaar, Hester F. Lingsma, Marjon H. Cnossen, Michiel Coppens, Karina Meijer, Paul R. van der Valk, Frank W.G. Leebeek, Renske M.T. ten Ham
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2026-01-01
Серія:	Research and Practice in Thrombosis and Haemostasis
Предмети:	hemophilia gene therapy health care resource cost microcosting
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2475037925005990
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!